Rajeev Venkayya, Aerium Therapeutics CEO

Born out of Omega push for pan­dem­ic treat­ments, Aeri­um Ther­a­peu­tics en­ters long Covid R&D

Aeri­um Ther­a­peu­tics, which Omega Funds seed­ed in 2021 and un­veiled in spring 2022 to take on Covid-19 with new mon­o­clon­al an­ti­bod­ies, will at­tempt to treat …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.